Tirzepatide for Weight Loss
US$ 27.24
pharma news today glp-1 obesity drugs Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat and other weight-related conditions WHO GLP-1 Treatments: WHO Endorses
Description
PAM plays a role in activating various hormones, including GLP-1
The catch is that your appetite-regulating hormones (leptin, ghrelin, PYY) remain dysregulated for 12-24 months, making weight regain likely through increased hunger and reduced satiety
Moving beyond food noise to drug noise, GLP-1s are quieting the roar of addiction. Cai M, Choi T, Xie Y, Al-Aly Z
J Med Soc (2017) 31:185
Programmable scheduled release microneedle patches (dissolvable) containing the GLP-1 drug semaglutide are under trial
